News

Filter

Current filters:

Human Genome Sciences

1 to 9 of 44 results

Pharma partnering dollars continue to decline, Burrill & Co reports

06-08-2012

The recent $3.4 billion partnering agreement announced in July between US pharma company Bristol-Myers…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbFinancialGlaxoSmithKlineHuman Genome SciencesLicensingMarkets & Marketing

Human Genome capitulates, accepting raised offer from GlaxoSmithKline

17-07-2012

Confirming weekend rumors (The Pharma Letter July 16), UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Human Genome resubmits raxibacumab BLA

11-07-2012

US biotech firm Human Genome Sciences (Nasdaq: HGSI), the subject of a hostile takeover bid from GlaxoSmithKline,…

Antibiotics and Infectious diseasesBiotechnologyHuman Genome SciencesNorth AmericaraxibacumabRegulation

GlaxoSmithKline $2.6 billion tender offer for Human Genome Sciences saga continues

02-07-2012

Continuing its attempts to gain control of its development partner Human Genome Sciences (Nasdaq: HGSI),…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Zacks analysts view progress of GSK bid for Human Genome Sciences

05-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) recently announced that the waiting period with respect to…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

1 to 9 of 44 results

COMPANY SPOTLIGHT

Menarini

Back to top